Literature DB >> 21347708

Regulation of mouse 4-1BB expression: multiple promoter usages and a splice variant.

Jung D Kim1, Chang H Kim, Byoung S Kwon.   

Abstract

The expression of 4-1BB has been known to be dependent on T cell activation. Recent studies have, however, revealed that 4-1BB expression is not restricted to T cells. We sought to determine the molecular basis for the differential gene expression. Here we report the expression pattern of two mouse 4-1BB transcripts, type I and type II. Whereas the type I transcript was specifically expressed on immune organ as previously reported, the type II transcript was ubiquitously expressed in tissues and various cell lines. However, both type I and type II transcript were highly induced on activated T cells. Primer extension assay of the two 4-1BB transcripts suggested that mouse 4-1BB had more than two transcripts. Using luciferase assay we have identified three promoter regions (PI, PII and PIII), which located on upstream region of second exon 1, first exon 1, and exon 2, respectively. In particular, the type I transcript was preferentially induced when naïve T cells are stimulated by anti-CD3 monoclonal antibody (mAb) since NF-κB specifically binds to the putative NF-κB element of PI. We have also shown that a splice variant, in which the transmembrane domain was deleted, could inhibit 4-1BB signaling. The splicing variant was highly induced by TCR stimulation. Our results reveal 4-1BB also has a negative regulation system through soluble 4-1BB produced from a splice variant induced under activation conditions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21347708      PMCID: PMC3932682          DOI: 10.1007/s10059-011-0018-6

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  56 in total

1.  Immortalization of human WI38 cells is associated with differential activation of the c-myc origins.

Authors:  L Tao; Z Dong; M Zannis-Hadjopoulos; G B Price
Journal:  J Cell Biochem       Date:  2001       Impact factor: 4.429

2.  Identification of a positive regulatory element in the myelin-specific promoter of the PMP22 gene.

Authors:  M Hai; S I Bidichandani; P I Patel
Journal:  J Neurosci Res       Date:  2001-09-15       Impact factor: 4.164

3.  CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor.

Authors:  Rebecca S McHugh; Matthew J Whitters; Ciriaco A Piccirillo; Deborah A Young; Ethan M Shevach; Mary Collins; Michael C Byrne
Journal:  Immunity       Date:  2002-02       Impact factor: 31.745

4.  Induction of 4-1BB (CD137) expression by DNA damaging agents in human T lymphocytes.

Authors:  Kwang-Mi Kim; Ho Won Kim; Jae-Ouk Kim; Kyoung-Min Baek; Joong Gon Kim; Chang-Yuil Kang
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

5.  CD137 activation abrogates granulocyte-macrophage colony-stimulating factor-mediated anti-apoptosis in neutrophils.

Authors:  I V Heinisch; I Daigle; B Knöpfli; H U Simon
Journal:  Eur J Immunol       Date:  2000-12       Impact factor: 5.532

6.  Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.

Authors:  I V Heinisch; C Bizer; W Volgger; H U Simon
Journal:  J Allergy Clin Immunol       Date:  2001-07       Impact factor: 10.793

7.  CD137 expression in tumor vessel walls. High correlation with malignant tumors.

Authors:  K Broll; G Richter; S Pauly; F Hofstaedter; H Schwarz
Journal:  Am J Clin Pathol       Date:  2001-04       Impact factor: 2.493

8.  Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells.

Authors:  Toshiro Futagawa; Hisaya Akiba; Tomohiro Kodama; Kazuyoshi Takeda; Yasuyuki Hosoda; Hideo Yagita; Ko Okumura
Journal:  Int Immunol       Date:  2002-03       Impact factor: 4.823

9.  Cutting edge: Expression of functional CD137 receptor by dendritic cells.

Authors:  Ryan A Wilcox; Andrei I Chapoval; Kevin S Gorski; Mizuto Otsuji; Tahiro Shin; Dallas B Flies; Koji Tamada; Robert S Mittler; Haruo Tsuchiya; Drew M Pardoll; Lieping Chen
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

10.  IRES-dependent translational control of Cbfa1/Runx2 expression.

Authors:  Zhou-Sheng Xiao; Leigh G Simpson; L Darryl Quarles
Journal:  J Cell Biochem       Date:  2003-02-15       Impact factor: 4.429

View more
  10 in total

Review 1.  Reverse signaling through the co-stimulatory ligand, CD137L, as a critical mediator of sterile inflammation.

Authors:  Sang Jun Park; Hye Jeong Kim; Jong Soo Lee; Hong Rae Cho; Byungsuk Kwon
Journal:  Mol Cells       Date:  2012-04-20       Impact factor: 5.034

2.  Several cis-regulatory elements control mRNA stability, translation efficiency, and expression pattern of Prrxl1 (paired related homeobox protein-like 1).

Authors:  Isabel Regadas; Mariana Raimundo Matos; Filipe Almeida Monteiro; José Luis Gómez-Skarmeta; Deolinda Lima; José Bessa; Fernando Casares; Carlos Reguenga
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

3.  Identification of alternative transcripts encoding the essential murine gammaherpesvirus lytic transactivator RTA.

Authors:  Brian S Wakeman; L Steven Johnson; Clinton R Paden; Kathleen S Gray; Herbert W Virgin; Samuel H Speck
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

4.  Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism.

Authors:  Sara Labiano; Asis Palazón; Elixabet Bolaños; Arantza Azpilikueta; Alfonso R Sánchez-Paulete; Aizea Morales-Kastresana; Jose I Quetglas; José L Perez-Gracia; Alfonso Gúrpide; Maria Rodriguez-Ruiz; M Angela Aznar; Maria Jure-Kunkel; Pedro Berraondo; Ignacio Melero
Journal:  Oncoimmunology       Date:  2015-06-24       Impact factor: 8.110

5.  Cross-talk between 4-1BB and TLR1-TLR2 Signaling in CD8+ T Cells Regulates TLR2's Costimulatory Effects.

Authors:  Ann Mary Joseph; Ratika Srivastava; Jovanny Zabaleta; Eduardo Davila
Journal:  Cancer Immunol Res       Date:  2016-06-07       Impact factor: 11.151

6.  4-1BB signaling breaks the tolerance of maternal CD8+ T cells that are reactive with alloantigens.

Authors:  Kwang H Kim; Beom K Choi; Jung D Kim; Young H Kim; Sun K Lee; Jae H Suh; Sang C Lee; Sang W Kang; Byoung S Kwon
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

7.  Regulation of CD137 expression through K-Ras signaling in pancreatic cancer cells.

Authors:  Christophe Glorieux; Peng Huang
Journal:  Cancer Commun (Lond)       Date:  2019-07-09

8.  CD137 expression in cancer cells: regulation and significance.

Authors:  Christophe Glorieux; Peng Huang
Journal:  Cancer Commun (Lond)       Date:  2019-11-08

Review 9.  The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity.

Authors:  Beom K Choi; Hyeon-Woo Lee
Journal:  Front Immunol       Date:  2020-12-10       Impact factor: 7.561

10.  Cellular dissection of psoriasis for transcriptome analyses and the post-GWAS era.

Authors:  William R Swindell; Philip E Stuart; Mrinal K Sarkar; John J Voorhees; James T Elder; Andrew Johnston; Johann E Gudjonsson
Journal:  BMC Med Genomics       Date:  2014-05-22       Impact factor: 3.063

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.